Fineline Cube

Follow:
14422 Articles
Mabwell Bioscience Secures Licensing Deal with TABUK Pharmaceutical for MENA Region
CompanyDeals

Mabwell Bioscience Secures Licensing Deal with TABUK Pharmaceutical for MENA Region

ImmunoTech Biopharm's CAR-T-19 Earns Breakthrough Therapy Designation for B-ALL Treatment
CompanyDrug

ImmunoTech Biopharm’s CAR-T-19 Earns Breakthrough Therapy Designation for B-ALL Treatment

Grand Pharmaceutical Group Secures Licensing Agreement for CORXEL's Nasal Sprays in Greater China
CompanyDeals

Grand Pharmaceutical Group Secures Licensing Agreement for CORXEL’s Nasal Sprays in Greater China

EOSVISION Ltd Secures Series A Funding to Advance Ophthalmic Implant Development
CompanyDeals

EOSVISION Ltd Secures Series A Funding to Advance Ophthalmic Implant Development

Jiangsu Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-4729 Peptide Drug
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-4729 Peptide Drug

VIVA Biotech Expands Global Footprint with New Boston Branch
Company

VIVA Biotech Expands Global Footprint with New Boston Branch

Siemens Healthineers AG Acquires Advanced Accelerator Applications to Boost PETNET Solutions
CompanyDeals

Siemens Healthineers AG Acquires Advanced Accelerator Applications to Boost PETNET Solutions

Angitia Biopharmaceuticals Secures USD 120 Million in Series C Financing for Musculoskeletal Treatments
CompanyDeals

Angitia Biopharmaceuticals Secures USD 120 Million in Series C Financing for Musculoskeletal Treatments

MDHC Life Technologies Secures Series C++ Funding to Boost Consumer Healthcare and Life Sciences
CompanyDeals

MDHC Life Technologies Secures Series C++ Funding to Boost Consumer Healthcare and Life Sciences

Bayer AG's Shanghai Co.Lab to Host Epigenic Therapeutics and Peers for CGT Innovation
Company

Bayer AG’s Shanghai Co.Lab to Host Epigenic Therapeutics and Peers for CGT Innovation

AstraZeneca's Lynparza Shows Sustained Improvements in OlympiA Phase III Study
CompanyDrug

AstraZeneca’s Lynparza Shows Sustained Improvements in OlympiA Phase III Study

Sanofi Receives FDA Fast-Track Designation for Influenza and COVID-19 Combo Vaccine Candidates
CompanyDrug

Sanofi Receives FDA Fast-Track Designation for Influenza and COVID-19 Combo Vaccine Candidates